Cargando…
Efficacy and safety of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis caused by novel coronavirus disease: A protocol for Bayesian network meta-analysis
BACKGROUND: Novel coronavirus disease (COVID-19) is a kind of pulmonary inflammation induced by New Coronavirus. It seriously threatens people's health and safety. Clinical studies have found that some patients have different degrees of inflammation after discharge from hospital, especially in...
Autores principales: | Li, Feiran, Wang, Guanyu, Zhang, Wei, Zhang, Caiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702149/ https://www.ncbi.nlm.nih.gov/pubmed/34941111 http://dx.doi.org/10.1097/MD.0000000000028282 |
Ejemplares similares
-
Traditional Chinese medicine for the treatment of pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview
por: Li, Li-Juan, et al.
Publicado: (2020) -
Chinese herbal medicines for the treatment of cough in idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis
por: Xiao, Siyao, et al.
Publicado: (2020) -
Effectiveness and safety of different traditional Chinese medicine therapies for allergic rhinitis: A protocol for systematic review and network meta analysis
por: Yu, Ting, et al.
Publicado: (2020) -
Efficacy and safety of Chinese medicines for asthma: A systematic review protocol
por: Shi, Qi, et al.
Publicado: (2019) -
Traditional Chinese medicine may reduce the dosage of systemic glucocorticoids in required patients with acute exacerbation of chronic obstructive pulmonary disease: Study protocol for a randomized placebo-controlled trial
por: Zhao, Keni, et al.
Publicado: (2020)